CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Redx Pharma PLC Company Snapshot
Redx Pharma PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Redx Pharma PLC with three other companies in this sector in UNITED KINGDOM : Fusion Antibodies PLC (2020 sales of £3.90 million [US$5.35 million] ), Silence Therapeutics Plc (£5.48 million [US$7.53 million] ), and Reneuron Group PLC (£6.07 million [US$8.33 million] of which 100% was Development of cell-based therapies).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Redx Pharma PLC
  Stock Performance Chart for Redx Pharma PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 67.50p
(Figures in Pounds Sterling)
1 Week 3.8%   13 Weeks 8.0%  
4 Weeks 8.0%   52 Weeks 350.2%  
 
Redx Pharma PLC Key Data:
  Ticker: REDX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 5,685,000
(Year Ending Jan 2021).
Employees: 52
  Currency: Pounds Sterling Market Cap: 131,859,516
  Fiscal Yr Ends: September Shares Outstanding: 195,347,430
  Share Type: Ordinary Closely Held Shares: 22,229,412
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.